1
|
Liang N, Zhang Y, Zhang X, Yan L, Zhao C, Yang S, Hu Z, Ye Z, Che Q, Liu B, Zhang H, Li H, Chen Z, Zhang Q, Wu T, Wang Y, Shi N, Huang L. International Traditional Medicine Clinical Trial Registry: A meaningful initiative and its future development. J Evid Based Med 2024; 17:486-489. [PMID: 39324999 DOI: 10.1111/jebm.12651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 09/16/2024] [Accepted: 09/17/2024] [Indexed: 09/27/2024]
Affiliation(s)
- Ning Liang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Yujing Zhang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Xuefei Zhang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Lijiao Yan
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
| | - Chen Zhao
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
| | - Sihong Yang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Ziteng Hu
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Zehui Ye
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
| | - Qianzi Che
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Bin Liu
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Haili Zhang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Huizhen Li
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Zhao Chen
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Qi Zhang
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- Former Head of Traditional, Complementary and Integrative Medicine Unit, World Health Organization, Geneva, Switzerland
| | - Taixiang Wu
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- Chinese Cochrane Centre, West China Hospital, Sichuan University, China Trial Registration Center, Chengdu, China
| | - Yanping Wang
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Nannan Shi
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing, China
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| | - Luqi Huang
- International Tratitional Medicine Clinical Trial Registry, Beijing, China
- China Center for Evidence-based Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China, Beijing, China
| |
Collapse
|
2
|
Zhang L, Li H, Hu L, Ou X, Tan H, Zhang X, Lau CT, Lyu A, Bian Z, Zhang X. Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study. Front Pharmacol 2024; 15:1389808. [PMID: 38910893 PMCID: PMC11190156 DOI: 10.3389/fphar.2024.1389808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Accepted: 05/14/2024] [Indexed: 06/25/2024] Open
Abstract
Objectives The impact of the Standard Protocol Items: Recommendations for Interventional Trials of Traditional Chinese Medicine (SPIRIT-TCM) Extension 2018 statement on the reporting quality of randomized controlled trial (RCT) protocols in traditional Chinese medicine (TCM) is not clear. This review aimed to assess the reporting characteristics and quality of RCT protocols involving interventions such as Chinese herbal medicine formulas (CHMF), acupuncture, and moxibustion published in the last 3 years. Methods We conducted an extensive search among multiple databases, including All EBM Reviews, Allied and Complementary Medicine (AMED), Embase, Ovid MEDLINE(R), PubMed, Web of Science, Google Scholar, and ClinicalTrials.gov for publications in English from 1 January 2020 to 10 August 2023. Two reviewers independently assessed the eligibility of the publications, extracted predetermined information, and evaluated the reporting based on the SPIRIT-TCM Extension 2018 checklist. Results Of the 420 eligible protocols (comprising 163 studies on CHMF, 239 on acupuncture, and 18 on moxibustion), the average reporting compliance rate was only 35.4%. Approximately half of the assessed items fell into the category of poorly reported, demonstrating a compliance rate below 65%. Notably, reporting compliance in acupuncture and moxibustion interventional studies exhibited higher scores than compliance in CHMF studies. Conclusion Continued, concerted, and coordinated efforts are required by journals, editors, reviewers, and investigators to improve the application and promotion of the SPIRIT-TCM Extension 2018 reporting guideline.
Collapse
Affiliation(s)
- Lin Zhang
- Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Han Li
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
| | - Lihan Hu
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
| | - Xiangqin Ou
- Guangdong Provincial Hospital of Chinese Medicine in Guizhou, Guizhou, China
| | - Hanzhi Tan
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
| | - Xuanqi Zhang
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
| | - Chung Tai Lau
- School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
| | - Aiping Lyu
- School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University, Kowloon, China
| | - Zhaoxiang Bian
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
- School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University, Kowloon, China
- Centre for Chinese Herbal Medicine Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
| | - Xuan Zhang
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China
- School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University, Kowloon, China
- Centre for Chinese Herbal Medicine Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China
| |
Collapse
|
3
|
Wang X, Yin X, Liu P, Wang A, Mu W, Xu J, Lu W, Chen Z, Zhou Y, Xu S, Wang Y. The effect of Baduanjin Qigong combined with five-elements music on anxiety and quality of sleep in asymptomatic patients with COVID-19 infection: A randomised controlled trial. Heliyon 2023; 9:e18962. [PMID: 37636423 PMCID: PMC10447985 DOI: 10.1016/j.heliyon.2023.e18962] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 07/31/2023] [Accepted: 08/03/2023] [Indexed: 08/29/2023] Open
Abstract
Background Infections of Coronavirus Disease-2019 (COVID-19) and the subsequent quarantine can culminate in anxious mood and sleep disturbances. The objective of this clinical trial was to investigate the effect of traditional Qigong with music therapy on relieving anxiety and improving the quality of sleep in Chinese adults with COVID-19 infection. Methods A total of 200 asymptomatic COVID-19 infected patients were randomly assigned into two groups during their quarantine period in Chongming Island, Shanghai. The patients in the treatment group daily received Baduanjin Qigong, five-elements music therapy and routine care, while the patients in the control group only took the routine care. The primary outcome was anxiety levels measured by the 7-item Generalized Anxiety Disorder scale (GAD-7). Secondary outcomes included the quality of sleep measured by the Jenkins Sleep Scale (JSS), the degree of depression measured by the Patient Health Questionnaire (PHQ-9), as well as the self-efficacy in the Perceived Health Competence Scale (PHCS). An online questionnaire was given to all participants on the day of arrival to determine the baseline for all outcomes and then given again on the day of discharge. A one-way analysis of covariance was used to analyze the differences between the two groups after intervention. Results At the end of the intervention, 177 (88.5%) patients finished the questionnaire. Patients in the treatment group had clearly decreased GAD-7 scores (MD = 2.7, 95% CI = 2.3, 3.2) after the daily exercise and music. Patients in the control group had little changes in the GAD-7 (MD = -0.2, 95%CI = -0.7, 0.3, P = 0.07), as well as the PHQ-9 (MD = 0.1, 95%CI = -0.5, 0.6, P = 0.66) after the routine care, when compared to their baseline scores. There were statistical between-group differences in GAD-7 (MD = 2.9, 95% CI = 2.2, 3.6, P < 0.001)and in the PHQ-9 scores (MD = 3.6, 95% CI = 2.9, 4.4, P < 0.001) at the post-treatment. Compared with the control group, patients had significantly lower scores on the JSS (MD = 2.7, 95% CI = 2.0, 3.3, P < 0.001), and higher scores on the PHCS (MD = -5.0, 95% CI = -6.1, -3.9, P < 0.001) after receiving Qigong and the music therapy. Conclusion Traditional Baduanjin Qigong and five-elements music therapy help to relieve anxiety and depression, and improve the sleep quality in patients with COVID-19 infection. Trial registration Chinese Clinical Trial Registry ChiCTR2200059800.
Collapse
Affiliation(s)
- Xian Wang
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Xuan Yin
- The Department of Acupuncture and Moxibustion, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Ping Liu
- The Department of Nursing, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
| | - Anzi Wang
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Wenfang Mu
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Jun Xu
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Weiyan Lu
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Zhuping Chen
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Yan Zhou
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Shifen Xu
- The Department of Acupuncture and Moxibustion, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| | - Yan Wang
- The Department of Nursing, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China
| |
Collapse
|
4
|
Promoting the quality and transparency of health research in China. J Clin Epidemiol 2022; 152:209-217. [PMID: 36220624 DOI: 10.1016/j.jclinepi.2022.10.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 09/13/2022] [Accepted: 10/02/2022] [Indexed: 11/18/2022]
Abstract
BACKGROUND AND OBJECTIVES To review the efforts and progress in promoting quality and transparency of health research in China and to discuss how to improve. METHODS We focused on three different types of health research: clinical trials, systematic reviews, and clinical practice guidelines, and summarized China's progress from their registration, implementation, and reporting stages. RESULTS In the last 3 decades, China's major works include the following: 1) For registration, the trials and CPGs registries have been set up, and released policies to mandate registration and submission of protocols for trials. 2) For implementation, multiple clinical research and EBM centers have been established. The ResMan platform for data management has been created and required researchers to share results data. 3) For reporting, the Chinese EQUATOR Center has been set up. Translations and extensions of the CONSORT, PRISMA, and RIGHT have been published. 4) For traditional Chinese medicine (TCM), specific guidelines for the registration and reporting of TCM research have been developed. CONCLUSION China has made progress in promoting research quality and transparency, especially in research registration and reporting. Nevertheless, more can be done in data management and sharing for research implementation, and good publication practices in TCM.
Collapse
|
5
|
Zhang X, Chung WCA, Lau CT, Wang N. Reporting guidelines of Chinese medicine: Current situation and future development. JOURNAL OF TRADITIONAL CHINESE MEDICAL SCIENCES 2022. [DOI: 10.1016/j.jtcms.2022.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/08/2022] Open
|
6
|
Stoll M, Kerwer M, Lieb K, Chasiotis A. Plain language summaries: A systematic review of theory, guidelines and empirical research. PLoS One 2022; 17:e0268789. [PMID: 35666746 PMCID: PMC9170105 DOI: 10.1371/journal.pone.0268789] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Accepted: 05/09/2022] [Indexed: 11/24/2022] Open
Abstract
Plain language summaries (PLSs) have been introduced to communicate research in an understandable way to a nonexpert audience. Guidelines for writing PLSs have been developed and empirical research on PLSs has been conducted, but terminology and research approaches in this comparatively young field vary considerably. This prompted us to review the current state of the art of the theoretical and empirical literature on PLSs. The two main objectives of this review were to develop a conceptual framework for PLS theory, and to synthesize empirical evidence on PLS criteria. We began by searching Web of Science, PubMed, PsycInfo and PSYNDEX (last search 07/2021). In our review, we included empirical investigations of PLSs, reports on PLS development, PLS guidelines, and theoretical articles referring to PLSs. A conceptual framework was developed through content analysis. Empirical studies investigating effects of PLS criteria on defined outcomes were narratively synthesized. We identified 7,714 records, of which 90 articles met the inclusion criteria. All articles were used to develop a conceptual framework for PLSs which comprises 12 categories: six of PLS aims and six of PLS characteristics. Thirty-three articles empirically investigated effects of PLSs on several outcomes, but study designs were too heterogeneous to identify definite criteria for high-quality PLSs. Few studies identified effects of various criteria on accessibility, understanding, knowledge, communication of research, and empowerment. We did not find empirical evidence to support most of the criteria we identified in the PLS writing guidelines. We conclude that although considerable work on establishing and investigating PLSs is available, empirical evidence on criteria for high-quality PLSs remains scarce. The conceptual framework developed in this review may provide a valuable starting point for future guideline developers and PLS researchers.
Collapse
Affiliation(s)
- Marlene Stoll
- Leibniz Institute for Psychology (ZPID), Trier, Germany
- Leibniz Institute for Resilience Research (LIR), Mainz, Germany
| | - Martin Kerwer
- Leibniz Institute for Psychology (ZPID), Trier, Germany
| | - Klaus Lieb
- Leibniz Institute for Resilience Research (LIR), Mainz, Germany
| | | |
Collapse
|
7
|
Haleem A, Javaid M, Singh RP, Suman R. Quality 4.0 technologies to enhance traditional Chinese medicine for overcoming healthcare challenges during COVID-19. DIGITAL CHINESE MEDICINE 2021. [DOI: 10.1016/j.dcmed.2021.06.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
8
|
Kuang Z, Li X, Cai J, Chen Y, Qiu X, Ni X. Calling for improved quality in the registration of traditional Chinese medicine during the public health emergency: a survey of trial registries for COVID-19, H1N1, and SARS. Trials 2021; 22:188. [PMID: 33673845 PMCID: PMC7934977 DOI: 10.1186/s13063-021-05113-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 02/09/2021] [Indexed: 12/25/2022] Open
Abstract
Objective To assess the registration quality of traditional Chinese medicine (TCM) clinical trials for COVID-19, H1N1, and SARS. Method We searched for clinical trial registrations of TCM in the WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) on April 30, 2020. The registration quality assessment is based on the WHO Trial Registration Data Set (Version 1.3.1) and extra items for TCM information, including TCM background, theoretical origin, specific diagnosis criteria, description of intervention, and outcomes. Results A total of 136 records were examined, including 129 severe acute respiratory syndrome coronavirus 2 (COVID-19) and 7 H1N1 influenza (H1N1) patients. The deficiencies in the registration of TCM clinical trials (CTs) mainly focus on a low percentage reporting detailed information about interventions (46.6%), primary outcome(s) (37.7%), and key secondary outcome(s) (18.4%) and a lack of summary result (0%). For the TCM items, none of the clinical trial registrations reported the TCM background and rationale; only 6.6% provided the TCM diagnosis criteria or a description of the TCM intervention; and 27.9% provided TCM outcome(s). Conclusion Overall, although the number of registrations of TCM CTs increased, the registration quality was low. The registration quality of TCM CTs should be improved by more detailed reporting of interventions and outcomes, TCM-specific information, and sharing of the result data. Supplementary Information The online version contains supplementary material available at 10.1186/s13063-021-05113-y.
Collapse
Affiliation(s)
- Zhuoran Kuang
- Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China
| | - Xiaoyan Li
- Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China
| | - Jianxiong Cai
- Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China
| | - Yaolong Chen
- Evidence-based Medicine Centre, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China. .,Chinese GRADE Centre, Lanzhou University, Lanzhou, 730000, China. .,WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, 730000, China.
| | - Xiaoyuan Qiu
- Guangzhou University of Chinese Medicine, Guangzhou, 510720, China
| | - Xiaojia Ni
- Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .,Guangdong Provincial Key Laboratory of Research on Emergency in TCM, Guangzhou, 510120, China.
| | | |
Collapse
|
9
|
Tian G, Zhao C, Zhang X, Mu W, Jiang Y, Wei X, Zhao M, Shi Z, Jin Y, Si J, Wang J, Hu J, Guan M, Qiu R, Zhong C, Li M, Sun Y, Chen Z, You L, Li J, Shang H. Evidence-based traditional Chinese medicine research: Two decades of development, its impact, and breakthrough. J Evid Based Med 2021; 14:65-74. [PMID: 33615709 DOI: 10.1111/jebm.12420] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2020] [Accepted: 11/13/2020] [Indexed: 11/29/2022]
Abstract
It has been over 20 years since the introduction of evidence-based medicine (EBM) into the research of traditional Chinese medicine (TCM). The development of evidence-based TCM research has profoundly influenced the process of clinical research and decision-making, impelling researchers to pay attention to raise evidence quality, accumulate data, and explore appropriate evaluation methods adaptive to TCM original theories and knowledge. In this paper, the authors aim to summarize and review the existing work and seek promising research interests in this field, expecting to inspire more thoughts leading to breakthroughs in the near future.
Collapse
Affiliation(s)
- Guihua Tian
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Chen Zhao
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
| | - Xiaoyu Zhang
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Wei Mu
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Yin Jiang
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Xuxu Wei
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Mengzhu Zhao
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Zhaofeng Shi
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Yinghui Jin
- Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
| | - Jinhua Si
- Library of Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Jiaying Wang
- Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
| | - Jiayuan Hu
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
| | - Manke Guan
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Ruijin Qiu
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Changming Zhong
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Min Li
- Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Yang Sun
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Zhao Chen
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Liangzhen You
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Jinyu Li
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Hongcai Shang
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
- International Evidence-based Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| |
Collapse
|